Loading…
B. Braun Medical Inc. has signed an agreement to acquire the bloodlines business operated under the Medisystems name by NxStage Medical Inc. The acquisition is subject to FTC approval and contingent upon NxStage's merger with Fresenius Medical Holdings, expected to close in 2018.
Fresenius Medical Care signed an agreement to acquire NxStage Medical, a U.S. medical technology company, for approximately $2.0 billion, to strengthen its home dialysis and critical care presence.